SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Interim Results

31 Jul 2013 15:17

RNS Number : 6315K
Silvermere Energy PLC
31 July 2013
 

31 July 2013

 

 

Silvermere Energy plc

("Silvermere" or the "Company")

 

Unaudited Interim Results for the Six Months ended 30 June 2013

 

Silvermere, the independent oil and gas company focusing principally on exploration, appraisal and production opportunities in the US, today announces its interim results for the six months ended 30 June 2013.

The Company's various announcements during 2013 have identified the reasons why the steady progress made through 2012 unfortunately stalled in 2013. Although the I-1 Well began to produce in February and March 2013, technical difficulties subsequently resulted in suspension of production. Additional expenditure on remedial works is required in order to attempt to recommence production. The fall in US gas prices as domestic supply of natural gas from fracking increases has also impacted the financial viability of the business.

Silvermere has more recently been unable to pay its share of the I-1 Well's development costs or to raise new finance, since the placing in January 2013, in which a placee failed to honour his commitment for £80,000. The technical difficulties and halted production at the I-1 Well have also impacted the Company's share price and commercial prospects and the Board has therefore been unable to follow its strategy of acquiring other producing assets.

Following the announcement on 9 May 2013 when the Directors requested trading in the Company's shares to be suspended on the AIM market, they have endeavoured to find the best solution for shareholders and creditors.

Working alongside the Company's major creditor, Mineral and Financial Investments Ltd ("MAFI"), the Board has ultimately determined that the best way forward would be to dispose of all or part of the Mustang Island asset to the operator in consideration for a release from past and future obligations and to turn the Company into a clean shell through a CVA. A number of parties expressed interest in financing a CVA and investing in the resulting shell and on 9 July 2013 the Company signed Heads of Terms and entered into exclusive discussions with a consortium of investors.

The Board is disappointed by this outcome. We trust shareholders will accept that the Board has played its hand as professionally as possible. We would like to thank the Board of MAFI, our major creditor, for its commitment to finding a solution and we wish the incoming Board good fortune in creating value for all shareholders.

 Frank H. Moxon

Non-executive Chairman

 

 

For further information please contact:

 

Silvermere Energy plc

Andy Morrison, Chief Executive

 

 

 

 

+44 (0)7980 878561

 

Sanlam Securities UK Limited (Nominated Adviser and Broker)

Simon Clements / Virginia Bull / Catherine Miles

 

Peterhouse Corporate Finance Limited

Heena Karani/ Duncan Vasey

 

 

+ 44(0)20 7628 2200 

 

 

+44 (0)20 7469 0933

 

Bishopgate Communications

Nick Rome/ Anna Michniewicz/ Ivana Petkova

 

+44(0)20 7562 3350

Unaudited Group Statement of Comprehensive Income

for the 6 months ended 30 June 2013

6 months to 30 June 2013

6 months to 30 June 2012

12 months to 31 December 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Administration costs

(401,975)

(585,164)

(994,871)

Exceptional items

-

-

(3,850,000)

Operating loss

(401,975)

(585,164)

(4,844,871)

Financial income

-

13

-

Finance costs

(122,503)

(86,947)

(190,147)

Loss before tax

(524,478)

(672,098)

(5,035,018)

Income tax

-

-

-

Loss for the period

(524,478)

(672,098)

(5,035,018)

Loss per share

Basic

(1.6p)

(3.2p)

(20.0p)

Diluted

(1.6p)

(3.2p)

(20.0p)

 

Unaudited Group Statement of Financial Position

as at 30 June 2013

 

30 June

 2013

30 June

 2012

31 December 2012

(Unaudited)

(Unaudited)

(Audited)

Note

£

£

£

Assets

Investment in oil and natural gas assets

320,594

3,804,929

247,865

Non-current assets

320,594

3,804,929

247,865

Current assets

Trade and other receivables

30,350

289,508

84,640

Cash and cash equivalents

17,973

703,668

19,248

48,323

993,176

103,888

Total assets

368,917

4,798,106

351,753

Equity attributable to the Company's equity holders

Share capital

4

1,301,913

1,296,547

1,296,607

Share premium

6,347,374

5,923,905

6,004,030

Loan note equity reserve

25,274

25,274

25,274

Share option and warrant reserve

795,699

795,689

795,699

Retained earnings

(9,556,010)

(4,688,612)

(8,081,532)

(1,085,750)

3,436,988

(909,922)

Current liabilities

Trade and other payables

1,365,215

747,368

1,175,399

Non-current liabilities

Borrowings

31,608

555,906

28,432

Decommissioning obligation

57,844

57,844

57,844

Total liabilities

1,454,667

1,361,118

1,261,675

Total equity and liabilities

368,917

4,798,106

351,753

 

 

 

Unaudited Group Statement of Cash flows

for the 6 months ended 30 June 2013

6 months to 30 June 2013

6 months to 30 June 2012

12 months to 31 December 2012

(Unaudited)

(Unaudited)

(Audited)

Note

£

£

£

Cash flows from operating activities

Cash used in operations

5

(149,438)

191,663

(290,634)

Net cash from operating activities

(149,438)

191,663

(290,634)

Cash flows from investing activities

Investment in oil and gas assets

(120,487)

(440,350)

(537,510)

Net cash from investing activities

(120,487)

(440,350)

(3,248,127)

Cash flows from financing activities

Proceeds on issue of shares

291,400

759,990

645,040

Share issue expenses

(22,750)

(10,000)

-

Finance income

-

13

-

Net cash from financing activities

268,650

750,003

645,040

Increase in cash and cash equivalents

(1,275)

501,316

(183,804)

Cash and cash equivalents at beginning of period

 

19,248

 

202,352

 

202,352

Cash and cash equivalents at end of period

17,973

703,668

 

19,248

 

Notes to the unaudited interim statement

for the 6 months ended 30 June 2013

 

1. General information

Silvermere Energy Plc is an investor in oil and gas assets.

The Company is a public limited company listed on AIM and is incorporated in England and Wales.

The address of its registered office is 31 Harley Street, London, W1G 9QS. Items included in the financial statements of the Company are measured in Pound Sterling which is the currency of the primary economic environment in which the entity operates. The financial statements are also presented in Pound Sterling which is the Company's presentational currency.

 

2. Basis of preparation

The interim financial statements of Silvermere Energy Plc have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union (EU) and on the historical cost basis using the accounting policies which are consistent with those set out in the Company's Annual Report and Accounts for the year ended 31 December 2012.

This interim financial information for the six months to 30 June 2013 was approved by the board on 29 July 2013.

The unaudited interim financial information for the period ended 30 June 2013 does not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2012 are extracted from the audited statutory financial statements for that period.

 

3. Loss per share

 

Loss per share is calculated by reference to the weighted average of 33,870,865 ordinary shares in issue during the period (30 June 2012 - 20,926,393 and 31 December 2012 - 25,117,597).

The diluted loss per share is the same as the basic loss per share as the losses in each period have an anti-dilutive effect.

 

4. Share capital

30 June 2013

30 June 2012

31 December 2012

Number

Number

Number

Issued and fully paid:

Ordinary shares of £0.001

34,545,072

29,179,310

29,239,356

Deferred shares of £29.999

42,247

42,247

42,247

£

£

£

Issued and fully paid:

Ordinary shares of £0.001

34,545

29,179

29,239

Deferred shares of £29.999

1,267,368

1,267,368

1,267,368

1,301,913

1,296,547

1,296,607

 

The deferred shares have negligible value, being subject to restrictions as to voting, participation and redemption according to the new Articles of Association then adopted, nor are they quoted on the Stock Exchange.

On 23 January 2013, 5,305,716 shares were issued for cash at 7p per share as a result of a private placing.

 

5. Note to the cash flow statement

6 months to 30 June 2013

6 months to 30 Jun 2012

12 months to 31 Dec 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Loss for the period

(524,478)

(672,098)

(5,035,018)

Adjustments for items not included in cash flow:

Share-based payment expense

-

20,600

20,610

Shares issued in lieu of fees and remuneration

-

3,000

123,950

Finance expense

122,503

86,947

190,147

Impairment expense

-

-

3,850,000

Provision for unpaid share capital

80,000

-

-

Finance income

-

(13)

-

(321,975)

(476,564)

(850,311)

Adjustments for changes in working capital:

- Decrease in trade and other receivables

54,290

163,204

368,072

- Increase) in trade and other payables

118,247

590,023

191,605

Cash generated from/(used in) operations

(149,438)

191,663

(290,634)

6. Availability of Interim results

Copies of the report will be available from the Company's office and also from the Company's website www.silvermere-energy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR NKDDDQBKDNON
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.